I look forward to leading the new institute at Weill Cornell and being on the frontlines of developing the next generation of innovative basic discoveries and translational clinical studies that will revolutionize our approaches to treat and prevent inflammatory bowel disease and other inflammatory diseases, Dr. Artis said.